Will molecular jackhammers have at least 50% tumour-free efficacy in Phase 2 clinical trials?

Gesundheit & MedizinOne-Off1J

Manifold MarketsKein KYCVerifizierte AuflösungsdatenGut kalibriert

Aktuelle Community-Prognose

Nein 80%

Prognostiker

Fragetyp

binary

Methodik

Play-money forecasting platform

Quellentyp

Prognose

Marktdaten

Aktualisiert vor 17 Stunden

Veraltet

31. Dez. 23, 16:21 UTC2. Jan. 28, 07:59 UTC

Trends

Ergebnis24hWahrscheinlichkeit

Regeln

See the paper Molecular Jackhammers Eradicate Cancer Cells By Vibronic-Driven Action in the journal Nature Chemistry https://twitter.com/burny_tech/status/1741300258406031421/photo/1

If at the end date, I confirm that clinical trials are actively moving forward, the end date will be extended.
Market will resolve early if I find out that researchers have decided that they are not moving forward.
(reworded Jan 3, 2024)

Datenproblem bei diesem Markt melden

Will molecular jackhammers have at least 50% tumour-free efficacy in Phase 2 clinical trials?

Will molecular jackhammers have at least 50% tumour-free efficacy in Phase 2 clinical trials?

Offene Märkte

Hantavirus pandemic in 2026?

FDA approves skin cancer vaccine by which date?

Ebola pandemic in 2026?

Measles cases in U.S. in 2026?

Will the FDA approve retatrutide?

When will the FDA reclassify BPC-157 to Category 1?

Häufige Fragen

Diesen Markt im Code oder in einem KI-Agenten nutzen

Offene Märkte

Hantavirus pandemic in 2026?

FDA approves skin cancer vaccine by which date?

Ebola pandemic in 2026?

Measles cases in U.S. in 2026?

Will the FDA approve retatrutide?

When will the FDA reclassify BPC-157 to Category 1?